Insulet (PODD) EPS (Basic) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Insulet (PODD) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 24.18% |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 24.57% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 19.63% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 50.64% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | -6.23% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 29.56% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 17.98% |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | 51.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.86% |
| Mar 31, 2026 | 56.13% |
| Dec 31, 2025 | 80.69% |
| Sep 30, 2025 | 165.04% |
| Jun 30, 2025 | 38.09% |
| Mar 31, 2025 | 7.96% |
| Dec 31, 2024 | 49.35% |
| Sep 30, 2024 | 82.12% |
| Jun 30, 2024 | 109.40% |
| Dec 31, 2023 | 96.71% |
| Sep 30, 2023 | 61.48% |
| Jun 30, 2023 | 20.50% |
| Mar 31, 2023 | 130.47% |
| Dec 31, 2022 | 43.74% |
| Sep 30, 2022 | -97.36% |
| Jun 30, 2022 | -186.72% |
| Mar 31, 2022 | 75.60% |
| Dec 31, 2021 | 36.87% |
| Sep 30, 2021 | 86.71% |
| Jun 30, 2021 | -135.38% |